ASMB
Assembly Biosciences Inc

4,220
Mkt Cap
$557.71M
Volume
281,812.00
52W High
$39.71
52W Low
$7.75
PE Ratio
-7.34
ASMB Fundamentals
Price
$35.26
Prev Close
$32.35
Open
$32.50
50D MA
$33.06
Beta
1.03
Avg. Volume
136,327.11
EPS (Annual)
-$6.69
P/B
3.05
Rev/Employee
$390,684.93
Loading...
Loading...
News
all
press releases
Assembly Biosciences, Inc. (NASDAQ:ASMB) Given Average Recommendation of "Moderate Buy" by Analysts
Shares of Assembly Biosciences, Inc. (NASDAQ:ASMB - Get Free Report) have received an average rating of "Moderate Buy" from the eight brokerages that are covering the firm, Marketbeat Ratings...
MarketBeat·13d ago
News Placeholder
More News
News Placeholder
Assembly Biosciences (NASDAQ:ASMB) Stock Price Down 8.3% - Time to Sell?
Assembly Biosciences (NASDAQ:ASMB) Shares Down 8.3% - Here's Why...
MarketBeat·19d ago
News Placeholder
Assembly Biosciences, Inc. (NASDAQ:ASMB) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Shares of Assembly Biosciences, Inc. (NASDAQ:ASMB - Get Free Report) have been assigned an average rating of "Moderate Buy" from the seven research firms that are presently covering the stock...
MarketBeat·1mo ago
News Placeholder
Assembly Biosciences (NASDAQ:ASMB) Releases Quarterly Earnings Results, Misses Estimates By $0.22 EPS
Assembly Biosciences (NASDAQ:ASMB - Get Free Report) issued its quarterly earnings data on Monday. The biopharmaceutical company reported ($0.72) earnings per share (EPS) for the quarter, missing the...
MarketBeat·1mo ago
News Placeholder
Supernus Pharmaceuticals (SUPN) Surpasses Q3 Earnings and Revenue Estimates
Supernus (SUPN) delivered earnings and revenue surprises of +23.17% and +5.52%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Assembly Biosciences (ASMB) Surges 9.8%: Is This an Indication of Further Gains?
Assembly Biosciences (ASMB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks·3mo ago
<
...
1
>

Latest ASMB News

View

Advertisement|Remove ads.

Advertisement|Remove ads.